Asian Journal of Social Pharmacy

Editor-in-Chief: Huang Taikang

Asian Journal of Social Pharmacy (AJSP) is peer-reviewed quarterly journal jointly hosted by Shenyang Pharmaceutical University. AJSP is dedicated to providing researchers, pharmacists, administrators, and educators working within the field of pharmacy worldwide with a platform of communication in the advancement and development in social pharmacy. The journal.. More

ISSN: 1818-0884

Research on Reimbursement Management of Innovative Drugs Abroad and Its Enlightenment to China

Yu Hanshuang, Huang Xianqin, Wang Huiyan, Sun Lihua

2024, 19 (1): 1–8;

Abstract ( 50 ) PDF (486KB) ( 42 )

Research and Enlightenment of Text Mining Applications in ADR from Social Media

Lin Xueyi, Pang Li, Huang Zhe, Lian Guiyu

2024, 19 (1): 9–19;

Abstract ( 33 ) PDF (571KB) ( 18 )

Research on the Status Quo and Optimization of Centralized Procurement of Coronary Stents

Zhang Yuting, Liu Xiaoxi

2024, 19 (1): 20–28;

Abstract ( 28 ) PDF (433KB) ( 10 )

Analytic Hierarchy Process for Technological Risks in the Process of Innovative Drug Development in China

Diao Yuanyuan, Wu Zhiang

2024, 19 (1): 29–42;

Abstract ( 25 ) PDF (614KB) ( 12 )

Comparative Study on the Policy of Multiplicity Issues in Clinical Trials at Home and Abroad

Gong Jingran, Chang Yingnan, Qiao Jiahui, Chen Yuwen

2024, 19 (1): 43–49;

Abstract ( 28 ) PDF (443KB) ( 10 )

An Overview of Quality Management of Therapeutic Vaccines in Clinical Trials in China

Lin Hansen, Tian Lijuan

2024, 19 (1): 50–57;

Abstract ( 23 ) PDF (428KB) ( 10 )

Problems and Countermeasures to Improve Clinical Trial Participants’ Compensation Rights in China

Yang Xiuqiao, Wen Ping, Lin Hong, Chen Wenhuan, Chen Yuwen

2024, 19 (1): 58–63;

Abstract ( 24 ) PDF (415KB) ( 6 )

Research on the Status Quo and Countermeasures of Human Resource Management Outsourcing in China’s Pharmaceutical Enterprises

Wang Jianing, Wang Shuling

2024, 19 (1): 64–71;

Abstract ( 21 ) PDF (420KB) ( 8 )

An Exploration of Organizational Development in the Process of Innovation and Transformation of Pharmaceutical Enterprises - Taking X Pharmaceutical Enterprise as an Example

Gao Lin, Sun Lihua

2024, 19 (1): 72–80;

Abstract ( 33 ) PDF (568KB) ( 6 )

Comparative Analysis of Profit Model of Typical Pharmaceutical O2O Enterprises in China

Qu Simeng, Wang Shuling

2024, 19 (1): 81–88;

Abstract ( 23 ) PDF (523KB) ( 8 )

Analysis of Patent Application Status of Scutellaria Barbata Industrial Chain Based on Patent Data

Zeng Yingying, Liu Tong, Liu Yue, Song Aiwei, Yuan Hongmei

2024, 19 (1): 89–97;

Abstract ( 21 ) PDF (1621KB) ( 7 )

Asian Journal Of Social Pharmacy